Chemiluminescence enzyme immunoassay based on magnetic nanoparticles for detection of hepatocellular carcinoma marker glypican-3

Chemiluminescence enzyme immunoassay based on magnetic nanoparticles for detection of hepatocellular carcinoma marker glypican-3

Glypican-3 (GPC3) is reported as a great promising tumor marker for hepatocellular carcinoma (HCC) diagnosis. Highly sensitive and accurate analysis of serum GPC3 (sGPC3), in combination with or instead of traditional HCC marker alpha-fetoprotein (AFP), is essential for early diagnosis of HCC. Bioma...

Full description

Bibliographic Details
Main Authors:	Qian-Yun Zhang, Hui Chen, Zhen Lin, Jin-Ming Lin
Format:	Article
Language:	English
Published:	Elsevier 2011-08-01
Series:	Journal of Pharmaceutical Analysis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2095177911000098

Similar Items

Comparison of chemiluminescence enzyme immunoassay based on magnetic microparticles with traditional colorimetric ELISA for the detection of serum Î±-fetoprotein
by: Qian-Yun Zhang, et al.
Published: (2012-04-01)

Glypican-3: A molecular marker for the detection and treatment of hepatocellular carcinoma
by: Tsung-Chieh Shih, et al.
Published: (2020-12-01)

Development of a chemiluminescent enzyme immunoassay to detect cadmium in cereal samples
by: Zhi-Li Xiao, et al.
Published: (2018-01-01)

Gold Magnetic Nanoparticles-based Chemiluminescent Immunoassay for Detection of Chloramphenicol in Milk
by: Wang Linyu, et al.
Published: (2017-01-01)

Glypican 3-Targeted Therapy in Hepatocellular Carcinoma
by: Takahiro Nishida, et al.
Published: (2019-09-01)

Novel chemiluminescence immunoassays
by: Richardson, A. P.
Published: (1984)

The Rapid Screening of Triazophos Residues in Agricultural Products by Chemiluminescent Enzyme Immunoassay.
by: Ge Chen, et al.
Published: (2015-01-01)

Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alpha-fetoprotein level for hepatocellular carcinoma diagnosis
by: Yejoo Jeon, et al.
Published: (2016-09-01)

Metalloporphyrin : catalysed chemiluminescence immunoassay
by: Bashirians, George Mamberi
Published: (1993)

Development of a highly sensitive and selective microplate chemiluminescence enzyme immunoassay for the determination of free thyroxine in human serum
by: Xu Wang, Hui Chen, Jin-Ming Lin, Xitang Ying
Published: (2007-01-01)

Glypican-3-Targeted Alpha Particle Therapy for Hepatocellular Carcinoma
by: Meghan M. Bell, et al.
Published: (2021-12-01)

Role of glypican-3 signaling pathways and therapeutic potential in hepatocellular carcinoma
by: CHEN Jie
Published: (2013-01-01)

Evaluation of a new chemiluminescence immunoassay for diagnosis of syphilis
by: Mo Xiaohui, et al.
Published: (2010-02-01)

Intratumoral reciprocal expression of monocarboxylate transporter 4 and glypican-3 in hepatocellular carcinomas
by: Kenji Yorita, et al.
Published: (2019-11-01)

Immunological efficacy of glypican-3 peptide vaccine in patients with advanced hepatocellular carcinoma
by: Nobuhiro Tsuchiya, et al.
Published: (2017-10-01)

Distinct diagnostic and prognostic values of Glypicans gene expression in patients with hepatocellular carcinoma
by: Jian-Yao Wang, et al.
Published: (2021-04-01)

Performance of Serum Glypican 3 in Diagnosis of Hepatocellular Carcinoma: A meta-analysis
by: Dahai Xu, et al.
Published: (2019-01-01)

Dysplastic nodules with glypican-3 positive immunostaining: a risk for early hepatocellular carcinoma.
by: Li Gong, et al.
Published: (2014-01-01)

DIAGNOSTIC ROLE OF SERUM DES-γ-CARBOXY PROTHROMBIN AND GLYPICAN-3 IN HEPATOCELLULAR CARCINOMA
by: Po-Heng Chuang, et al.
Published: (2007)

Highly Specific Chemiluminescence Immunoassay for the Determination of Chloramphenicol in Cosmetics
by: Qiyan Li, et al.
Published: (2019-01-01)

Chemiluminescence based immunoassay for the detection of heroin and its metabolites
by: Smritee Singh, et al.
Published: (2018-01-01)

Comparison of chemiluminescent microparticle immunoassay (CMIA) with electrochemiluminescence immunoassay (ECLIA) for Carcinoembryonic antigen (CEA)
by: Nafija Serdarevic, et al.
Published: (2018-09-01)

Glypican-3 Antibody-Conjugated Magnetic Mesoporous Hydroxyapatite Nanoparticles for Chemohyperthermia of Liver Cancer Therapy
by: Sheng-Chih Lin, et al.
Published: (2016)

ELISA and Chemiluminescent Enzyme Immunoassay for Sensitive and Specific Determination of Lead (II) in Water, Food and Feed Samples
by: Long Xu, et al.
Published: (2020-03-01)

Comparison of chemiluminescence immunoassay, enzyme-linked immunosorbent assay and passive agglutination for diagnosis of Mycoplasma pneumoniae infection
by: Chen DM, et al.
Published: (2018-06-01)

Development of a highly sensitive chemiluminescent enzyme immunoassay for fragmented cytokeratin 18 using new antibodies
by: Minori Yamada, et al.
Published: (2021-09-01)

Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in Hepatocellular Carcinoma
by: Meng Jia, et al.
Published: (2021-04-01)

Comparison of the Chemiluminescence Immunoassay LIAISON® with the Radioimmunoassay for Aldosterone and Renin Measurement
by: Jana Uhrová, et al.
Published: (2021-06-01)

The fabrication of magnetic particle-based chemiluminescence immunoassay for human epididymis protein-4 detection in ovarian cancer
by: Xiaoling Fu, et al.
Published: (2018-03-01)

POE Immunoassay: Plate-based oligonucleotide electro-chemiluminescent immunoassay for the quantification of nucleic acids in biological matrices
by: Mai B. Thayer, et al.
Published: (2020-06-01)

Effect of AU-rich element RNA-binding factor 1 on the level of glypican 3 in hepatocellular carcinoma
by: ZHANG Ting
Published: (2021-05-01)

Glutamine synthetase, Glypican-3 and Arginase-1 expression in the differential diagnosis of hepatocellular carcinoma vs. metastatic carcinomas of the liver
by: A. Argon, et al.
Published: (2019-05-01)

Evaluation of Performance Characteristics of Enzyme Chemiluminescence Immunoassay (ECLIA) and Rapid Diagnostic Test (RDT) for HBV, HIV and HCV Infections
by: Dipmala Das, et al.
Published: (2018-08-01)

Development of a New Chemiluminescent Enzyme Immunoassay Using a Two-Step Sandwich Method for Measuring Aldosterone Concentrations
by: Yoshinori Ozeki, et al.
Published: (2021-03-01)

Development of chemiluminescence immunoassay for the measurement of plasma steroids and urinary steroid glucuronides
by: Kim, Jong Bae
Published: (1983)

Diagnostic efficacy of chemiluminescence immunoassay versus radioimmunoassay in screening primary aldosteronism
by: HONG Yangning, et al.
Published: (2019-11-01)

Development and evaluation of the magnetic particle-based chemiluminescence immunoassay for rapid and quantitative detection of Aflatoxin B1 in foodstuff
by: Gang Xie, et al.
Published: (2018-01-01)

Suppression of Glypican 3 Inhibits Growth of Hepatocellular Carcinoma Cells through Up-Regulation of TGF-β2
by: Chris K. Sun, et al.
Published: (2011-08-01)

Clinical significance of glypican-3-positive circulating tumor cells of hepatocellular carcinoma patients: A prospective study.
by: Michinori Hamaoka, et al.
Published: (2019-01-01)

Glypican-3 targeted delivery of 89Zr and 90Y as a theranostic radionuclide platform for hepatocellular carcinoma
by: Kevin P. Labadie, et al.
Published: (2021-02-01)